HBOT is effective in prolonging and enhancing the quality of life for patients with AIDS and in treating neurovascular complications. It is an effective adjunctive therapy in opportunistic infections. With few exceptions, HBOT treatment can be used palliatively in late-stage AIDS to enhance appetite, relieve hypoxia, and increase mental clarity. It can be administered at 1.5-2.0 ATA for thirty minutes daily.
The exceptions to using HBOT in the terminal phase are cases of pulmonary Kaposi’s sarcoma, seizure disorders, and obstructive cardiovascular complications.